Wells Fargo’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
47,132
-14,867
-24% -$500K ﹤0.01% 3597
2025
Q4
$2.66M Buy
61,999
+1,171
+2% +$44.1K ﹤0.01% 3217
2025
Q3
$1.72M Sell
60,828
-38,016
-38% -$1.14M ﹤0.01% 3416
2025
Q2
$1.85M Buy
98,844
+90,046
+1,023% +$1.71M ﹤0.01% 3269
2025
Q1
$158K Buy
8,798
+195
+2% +$3.96K ﹤0.01% 4847
2024
Q4
$145K Buy
8,603
+2,648
+44% +$50.8K ﹤0.01% 4983
2024
Q3
$96.4K Sell
5,955
-86
-1% -$1.01K ﹤0.01% 5045
2024
Q2
$49.7K Buy
6,041
+751
+14% +$7.86K ﹤0.01% 5289
2024
Q1
$78.3K Buy
5,290
+701
+15% +$9.45K ﹤0.01% 5039
2023
Q4
$66.5K Buy
4,589
+849
+23% +$8.68K ﹤0.01% 5149
2023
Q3
$40.4K Sell
3,740
-3,651
-49% -$43.9K ﹤0.01% 5291
2023
Q2
$95.3K Buy
7,391
+3,878
+110% +$52.4K ﹤0.01% 5069
2023
Q1
$46.4K Buy
3,513
+3,466
+7,374% +$55.1K ﹤0.01% 5194
2022
Q4
$705 Sell
47
-316
-87% -$2.9K ﹤0.01% 6290
2022
Q3
$5K Sell
363
-1,288
-78% -$17.4K ﹤0.01% 5923
2022
Q2
$19K Sell
1,651
-19,044
-92% -$382K ﹤0.01% 5482
2022
Q1
$618K Sell
20,695
-7,624
-27% -$206K ﹤0.01% 4259
2021
Q4
$750K Buy
28,319
+7,220
+34% +$218K ﹤0.01% 4350
2021
Q3
$767K Sell
21,099
-111,813
-84% -$4.4M ﹤0.01% 4410
2021
Q2
$5.77M Buy
132,912
+61,571
+86% +$2.32M ﹤0.01% 2733
2021
Q1
$2.44M Buy
71,341
+29,988
+73% +$1.19M ﹤0.01% 3516
2020
Q4
$1.45M Sell
41,353
-13,938
-25% -$404K ﹤0.01% 3737
2020
Q3
$1.33M Sell
55,291
-60,849
-52% -$1.49M ﹤0.01% 3644
2020
Q2
$2.13M Buy
116,140
+52,213
+82% +$939K ﹤0.01% 3221
2020
Q1
$997K Buy
63,927
+31,347
+96% +$667K ﹤0.01% 3548
2019
Q4
$698K Sell
32,580
-3,700
-10% -$76.2K ﹤0.01% 4112
2019
Q3
$678K Sell
36,280
-589
-2% -$12.2K ﹤0.01% 4150
2019
Q2
$963K Buy
36,869
+8,832
+32% +$199K ﹤0.01% 3891
2019
Q1
$720K Buy
28,037
+18,810
+204% +$430K ﹤0.01% 4114
2018
Q4
$212K Buy
9,227
+538
+6% +$15.2K ﹤0.01% 4869
2018
Q3
$279K Buy
8,689
+5
+0.1% +$150 ﹤0.01% 4822
2018
Q2
$246K Sell
8,684
-217
-2% -$7.72K ﹤0.01% 4917
2018
Q1
$315K Buy
8,901
+107
+1% +$4.28K ﹤0.01% 4713
2017
Q4
$341K Sell
8,794
-32,681
-79% -$1.24M ﹤0.01% 4670
2017
Q3
$1.05M Buy
41,475
+22,353
+117% +$544K ﹤0.01% 3817
2017
Q2
$522K Buy
19,122
+7,912
+71% +$217K ﹤0.01% 4195
2017
Q1
$371K Buy
11,210
+4,560
+69% +$116K ﹤0.01% 4441
2016
Q4
$158K Buy
6,650
+3,230
+94% +$92.5K ﹤0.01% 4894
2016
Q3
$126K Buy
3,420
+990
+41% +$28.4K ﹤0.01% 4765
2016
Q2
$54K Sell
2,430
-686
-22% -$17.1K ﹤0.01% 5168
2016
Q1
$65K Buy
3,116
+647
+26% +$16K ﹤0.01% 5111
2015
Q4
$75K Sell
2,469
-585
-19% -$17.7K ﹤0.01% 5108
2015
Q3
$76K Sell
3,054
-404
-12% -$12.1K ﹤0.01% 5071
2015
Q2
$111K Buy
3,458
+2,344
+210% +$89.5K ﹤0.01% 5003
2015
Q1
$40K Buy
1,114
+670
+151% +$18.4K ﹤0.01% 5110
2014
Q4
$10K Buy
444
+3
+0.7% +$61 ﹤0.01% 5634
2014
Q3
$9K Sell
441
-356
-45% -$10.1K ﹤0.01% 5635
2014
Q2
$30K Buy
797
+699
+713% +$23.8K ﹤0.01% 5181
2014
Q1
$4K Hold
98
﹤0.01% 5590
2013
Q4
$3K Sell
98
-62
-39% -$1.82K ﹤0.01% 5487
2013
Q3
$6K Hold
160
﹤0.01% 5245
2013
Q2
$5K Buy
+160
New +$7.25K ﹤0.01% 5219

Other funds holding RIGL